CEFOTUNE 500
General Range

CEFOTUNE 500

Fortune LabsPanchkula, Haryana

Price on request/100 · MOQ 100 boxes

CEFOTUNE 500 Tablets by Fortune Labs contain Cefuroxime Axetil 500 mg, a second-generation cephalosporin antibiotic used to treat infections caused by susceptible bacteria. Cefuroxime Axetil works by inhibiting bacterial cell wall synthesis, helping eliminate infection-causing microorganisms. CEFOTUNE 500 may be prescribed for selected respiratory tract infections, sinusitis, throat infections, urinary tract infections, and skin infections when clinically appropriate. Available in convenient 10 × 1 × 6 tablet blister packaging, this product is part of Fortune Labs' pharmaceutical portfolio. Fortune Labs offers PCD Pharma Franchise and distribution opportunities across India. Contact Fortune Labs for wholesale pricing, product availability, monopoly franchise opportunities, and business enquiries. This prescription antibiotic should be used only under medical supervision.

CategoryGeneral Range
Min. Order100 boxes
Supplied byFortune Labs
CertificationWHO-GMP, ISO

Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.

View Company

Specifications

Composition
Cefuroxime Axetil 500 mg
Packaging Type
Blister Pack
Packaging Size
10 × 1 × 6
Dosage Form
Tablet
Treatment
Bacterial respiratory tract infections, throat infections, sinusitis, ear infections, urinary tract infections, and certain skin and soft tissue infec
Shelf Life
24 Months
Storage
Store below 30°C, protect from light & moisture
Certification
WHO-GMP, ISO

Company Info

Fortune LabsPanchkula, Haryana
View Full Profile

Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.

Key Details

• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.

Product Portfolio & Therapeutic Ranges

• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?

More General Range